poisar

Stocks · News reference

Cuprina Holdings shares are trading lower after the company announced pricing of $4.97 million public offering.

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CUPR
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering

    Cuprina Holdings (Nasdaq: CUPR), a biomedical company focused on chronic wounds, infertility, medical waste recycling, and cosmeceuticals, closed its public offering of 4.32 million Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds. The company plans to use net proceeds for R&D expansion, new market entry, brand building, and infrastructure investment. The offering follows FDA 510(k) clearance for MEDIFLY Maggots™ in June.

    CUPR